Wet Age-related Macular Degeneration | Drugs Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

70,359 results for “Wet Age-related Macular Degeneration”

undisclosed tyrosine kinase inhibitor (Durasert, wet age-related macular degeneration)

RAGE-immunoglobulin fusion protein (diabetes/Dry and Wet age related macular degeneration/Covid-19)

Pegaptanib

Conditions: Neovascular Age-Related Macular Degeneration (nAMD)

FOV-RD27

LYN-002

Aflibercept(Eylea, Zaltrap, Yesafili, Eydenzelt, Ahzantive, Afqlir, Baiama, Opuviz, Pavblu, Mynzepli, Vgenfli, Eiyzey)

Conditions: Branch Retinal Vein Occlusion With Macular Edema, Diabetic Macular Edema (DME) +7 more

Rx

Age-Related Macular Degeneration(EyebioKorea)

antibodies (age related macular degeneration)

Age-related Macular Degeneration (InNexus)

age-related macular degeneration therapy

Page 1 of 119